Page 43 - Biontech Se News Today

European stocks are expected to open in positive territory on Thursday as investors continue to monitor developments around the omicron Covid variant.

Covid 19 live updates,covid 19 december 9 live updates,coronavirus live updates,coronavirus december 9 live updates,covid 19,covid 19 live,coronavirus,covid pandemic,covishield,covaxin,zydus cadila, BioNTech SE,Pfizer Inc,Business,Health care industry,Politics,U.S. Economy,Biotech and Pharmaceutical

Pfizer Inc. and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine may be needed to neutralize the omicron variant, results that will accelerate booster-shot drives around the world and may lead to use of new strain-spec

“The omicron data is enormously worrying,” immunologist Danny Altmann told CNBC, pointing to the U.K’s 2.5-day doubling time of cases.

European stocks are expected to open in positive territory on Thursday as investors continue to monitor developments around the omicron Covid variant.

Pfizer says its booster offers strong protection against omicron

European stocks are expected to open in positive territory on Thursday as investors continue to monitor developments around the omicron Covid variant.

European stocks traded in positive territory on Thursday as investors continue to monitor developments around the omicron Covid variant.

“The omicron data is enormously worrying,” immunologist Danny Altmann told CNBC, pointing to the U.K’s 2.5-day doubling time of cases.

Two vaccine doses were significantly less effective against variant but could still protect against severe disease, Pfizer and BioNTech say